LISA HAREWOOD: Open Payments
NPI 1124094537 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,378 in 156 payments from 18 companies in 2025. Trend: 2023 $2,463 · 2024 $2,592 · 2025 $3,378
Food & beverage: $3,279Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $447 |
| ABBVIE INC. | 19 | $397 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $375 |
| Regeneron Healthcare Solutions, Inc. | 16 | $347 |
| Novartis Pharmaceuticals Corporation | 12 | $241 |
| UCB, Inc. | 7 | $225 |
| Incyte Corporation | 8 | $221 |
| Amgen Inc. | 9 | $210 |
| Janssen Biotech, Inc. | 8 | $170 |
| Arcutis Biotherapeutics, Inc. | 14 | $159 |
Products named: DUPIXENT, RINVOQ, Bimzelx, OPZELURA, Otezla, TREMFYA, COSENTYX, Zoryve.
Industry payments across NC — which companies pay providers there.
